Type(s) of colorectal cancer (CRC)-Mucinous cystadenocarcinoma of the appendix Posts on Medivizor
Navigation Menu

Type(s) of colorectal cancer (CRC)-Mucinous cystadenocarcinoma of the appendix Posts on Medivizor

Radiofrequency ablation may slow down the progression of metastatic colorectal cancer

Radiofrequency ablation may slow down the progression of metastatic colorectal cancer

Posted by on Mar 5, 2013 in Colorectal cancer | 0 comments

In a nutshell This report aimed to establish if radiofrequency ablation (RFA) of liver metastases originating from colorectal cancer (CRC) provides any benefits to patients with Stage IV of the disease. Main result: RFA extends progression-free survival by 7 months. Some background RFA is a medical procedure for treating patients with small tumors...

Read More

Metastatic colorectal cancer: the benefit of combining cetuximab with chemotherapy

Metastatic colorectal cancer: the benefit of combining cetuximab with chemotherapy

Posted by on Mar 5, 2013 in Colorectal cancer | 0 comments

In a nutshell The present study investigated if patients with spread colorectal cancer that have mutations in the KRAS gene benefit from Cetuximab treatment. Some background Cancer that originates in the colon or rectum (parts of the intestine) is called colorectal cancer (CRC). If the cancer has spread from its original location, beyond the...

Read More

Comparison of two surgical techniques for the treatment of pseudomyxoma peritonei

Comparison of two surgical techniques for the treatment of pseudomyxoma peritonei

Posted by on Mar 4, 2013 in Colorectal cancer | 1 comment

In a nutshell The present study compared the efficacy of two surgical techniques to treat pseudomyxoma peritonei (PMP): debulking and cytoreduction. Cytoreductive surgery achieved better surgical results and yielded higher 3- and 5-year survival rates, compared with debulking. Some background PMP is a rare condition caused by the production of...

Read More

Evaluating the benefits of postoperative chemotherapy for patients with stage II colorectal cancer

Evaluating the benefits of postoperative chemotherapy for patients with stage II colorectal cancer

Posted by on Feb 24, 2013 in Colorectal cancer | 0 comments

In a nutshell This study tested whether chemotherapy after surgery (adjuvant chemotherapy) extends survival and reduces the risk of cancer recurrence in patients with stage II colorectal cancer (CRC). Some background Stage II colorectal cancer (cancer in the colon or rectum) is confined to the digestive tract. It is usually treated with surgery...

Read More